Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) Phase 3 Data from Two Lennox-Gastaut Syndrome Studies of Epidiolex Due mid-2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 27, 2016
Occurred Source:
http://ir.gwpharm.com/releasedetail.cfm?ReleaseID=977116
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Data, Lennox-gastaut Syndrome, Epilepsy, Epidiolex, Pharmaceutical Cannabidiol
